Karo Healthcare enters an exclusive license agreement with Moberg Pharma for MOB-015 in Europe

STOCKHOLM, Nov. 5, 2025 /PRNewswire/ -- Karo Healthcare AB ("Karo") has entered an exclusive licensing agreement with Moberg Pharma AB ("Moberg Pharma") regarding the commercialisation of MOB-015 in Europe. The agreement comprises 19 European markets, enabling a coordinated launch across...